These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5028401)

  • 1. Neurogenic bladder in Parkinson's disease.
    Greenberg M; Gordon HL; McCutchen JJ
    South Med J; 1972 Apr; 65(4):446-8. PubMed ID: 5028401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurogenic bladder disturbances in Parkinson's disease (author's transl)].
    Schneider E; Patras L; Fischer PA
    Fortschr Neurol Psychiatr Grenzgeb; 1978 May; 46(5):260-8. PubMed ID: 248041
    [No Abstract]   [Full Text] [Related]  

  • 3. Symptomatic neurogenic bladder in a cerebral-palsied population.
    McNeal DM; Hawtrey CE; Wolraich ML; Mapel JR
    Dev Med Child Neurol; 1983 Oct; 25(5):612-6. PubMed ID: 6354799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical neurogenic bladder in children.
    Dorfman LE; Bailey J; Smith JP
    J Urol; 1969 Jan; 101(1):48-54. PubMed ID: 4882624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative assessment of combined therapy of neurogenic hyperactivity of detrusor in patients with Parkinson's disease].
    Loran OB; Fedorova NV; Mazurenko DA; Khitarishvili EV
    Urologiia; 2006; (2):37-9, 41. PubMed ID: 16708587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
    Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenic dysfunction of the urinary bladder in Parkinson's disease.
    Foote J; Dejong JD
    Prim Care; 1977 Sep; 4(3):463-73. PubMed ID: 264223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergics for the uninhibited neurogenic bladder.
    Belker AM
    N Engl J Med; 1973 Aug; 289(7):378. PubMed ID: 4718523
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurogenic bladder in parkinsonism: effect of thalamotomy.
    Porter RW; Bors E
    J Neurosurg; 1971 Jan; 34(1):27-32. PubMed ID: 4924209
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical reevaluation of the effect of oxybutynin chloride on uninhibited neurogenic and reflex neurogenic bladder.
    Kawabe K; Abe S; Kanda T; Tei K
    Urol Int; 1986; 41(1):16-20. PubMed ID: 3962017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [neurogenic bladder and urinary tract infections].
    Park YC; Kurita T
    Nihon Rinsho; 1986 Dec; 44(12):2683-7. PubMed ID: 3546828
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology of the neurogenic bladder.
    Pedersen E; Grynderup V
    Acta Neurol Scand; 1966; 42(S20):111-120. PubMed ID: 5328648
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurogenic diseases of the bladder in the geriatric population.
    Tarabulcy E
    Geriatrics; 1974 Sep; 29(9):123-8 passim. PubMed ID: 4853327
    [No Abstract]   [Full Text] [Related]  

  • 15. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical findings of neurogenic bladder in patients with Parkinson's disease, multiple sclerosis and spinocerebellar degeneration].
    Shimizu K; Yasukawa M; Yamamoto M; Hirao Y; Momose H; Kashiwai H; Kawata Y; Yamada K
    Hinyokika Kiyo; 1997 Nov; 43(11):765-9. PubMed ID: 9436018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
    Greenfield SP; Fera M
    J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease; acute urinary retention.
    Lieberman AN; Lebowitz A; Leibowitz M; Tessler A
    N Y State J Med; 1980 Jul; 80(8):1285-6. PubMed ID: 6931315
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the vesicourethral function between progressive supranuclear palsy and Parkinson's disease].
    Wakatsuki A; Tsujihata M; Miyake O; Ito H; Itatani H; Udaka F
    Hinyokika Kiyo; 1993 Jun; 39(6):523-8. PubMed ID: 8337978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticholinergic effects of dicyclomine hydrochloride in uninhibited neurogenic bladder dysfunction.
    Fischer CP; Diokno A; Lapides J
    J Urol; 1978 Sep; 120(3):328-9. PubMed ID: 682250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.